MedTrace Logo

Myocardial Infarction Genes (MI-GENES) Study

NCT01936675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2016-05-03

No results posted yet for this study

Summary

This study is being done to better understand how genetic information might improve assessment of heart attack risk.

Conditions

Interventions

OTHER

Genetic Risk Score

Patients in this arm will receive their genetic-informed risk for having a heart attack.

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Iftikhar Kullo, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01936675 on ClinicalTrials.gov